News ArchivesRead News
Scientists Make Parkinson’s Breakthrough
Thursday December 22, 2005
19th December 2005(UK News) - British scientists have made a major breakthrough in the battle against Parkinson’s Disease, it was revealed today.
Researchers have discovered 570 abnormally acting genes that could help doctors predict and beat the crippling condition.
The boxer Muhammad Ali, the actor Michael J Fox and former Arsenal and Liverpool footballer Ray Kennedy are famous victims, but there are hundreds of thousands of sufferers in the UK and more than a million in the US.
Now scientists believe they are closing in on the genes responsible for the disease and could help doctors diagnose it earlier and provide targets for new treatments.
The research uses microarrays to analyse the brain of Parkinson’s patients. Microarrays are laboratory chips able to pick out which genes are active when different processes are occurring in the brain.
When scientists analysed brains from Parkinson’s sufferers, it was revealed that out of all 25,000 human genes, regulation of 570 was highly abnormal in Parkinson’s brains compared with non-diseased brains. The revolutionary study is the first on Parkinson’s disease where all human genes were studied.
The research published in Neurogenetics, by a team from Imperial College London and the University of Liege, Belgium, analysed 23 brains from recently deceased corpses, 15 affected by Parkinson’s and 8 control brains.
Most of the brains were provided by the UK Parkinson’s Disease Society Tissue Bank at Imperial College London.
Dr Linda Moran from Imperial College London, one of the authors of the paper, said: "This research highlights the considerable number of genes associated with the development of Parkinson’s, potentially providing new clues for how to treat this disease. Now that we can identify these genes it may be possible to develop new therapies to help the increasing numbers of Parkinson’s patients."
The research team, led by Professor Manuel Graeber, analysed two parts of the brain affected by neurodegeneration in Parkinson’s; the substantia nigra in the mid-brain, and the cerebral cortex.
They eliminated around 15,000 genes from playing any role in the development of the disease, as they were not found to be active in the substantia nigra, the part of the brain most affected by Parkinson’s.
Dawn Duke, MS, from Imperial College London, another of the authors of the paper said: "In addition to identifying those genes linked with the development of Parkinson’s, this research has also shown that many of these genes were especially active in Parkinson’s brains. By limiting the activity of these genes, we may be able to control or even stop the development of Parkinson’s."
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright